Roche Diagnostics launches campaign to promote widest panel of assays on an automated serum work area platform

Roche systems reduce testing complexity and improve efficiency at Princess Elizabeth Hospital, Guernsey

The UK’s life sciences trade associations – the Association of British Healthcare Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the British In Vitro Diagnostic Association (BIVDA) – believe the package of measures announced today by the Office for Life Sciences in its “Life Sciences Blueprint” provide an excellent basis for firmly securing the future of the life sciences sector and re-establishing the UK’s global competitive position

Oxoid, a world leading microbiology brand, is pleased to announce that the ProSpecT™ range of qualitative enzyme immunoassays has recently been extended to include test kits for Adenovirus, Astrovirus, Clostridium difficile, Campylobacter, Cryptosporidium, Entamoeba histolytica, Giardia, Giardia/Cryptosporidium, Rotavirus, Shiga Toxin Escherichia coli.

Troponin T high sensitive assay from Roche Diagnostics allows laboratories to consolidate cardiac assays on a single integrated chemistry and immunoassay platform

Stand number 115 - The new ARCHITECT ci4100 integrated clinical chemistry & immunoassay analyser will be on display at the Abbott Diagnostics stand at the 2009 IBMS Congress.

Randox have launched Drugs of Abuse (DoA) reagents for use on the RX Series of Clinical Chemistry Analysers. You can now detect 10 drugs of abuse in human urine on quality systems offering time, labour and cost savings.

The life sciences industry welcomes Lord Mandelson’s announcement of the creation of an Innovation Fund which will be corner-stoned by Government with investment from private investors.

Hospital laboratories rely on Roche Enzymatic Creatinine Assay for specific and reliable results